BriaCell Therapeutics BCTX Stock
BriaCell Therapeutics Price Chart
BriaCell Therapeutics BCTX Financial and Trading Overview
| BriaCell Therapeutics stock price | 11 USD |
| Previous Close | 0.83 USD |
| Open | 0.81 USD |
| Bid | 0.79 USD x 1100 |
| Ask | 0.82 USD x 1100 |
| Day's Range | 0.79 - 0.83 USD |
| 52 Week Range | 0.35 - 9.82 USD |
| Volume | 1.56M USD |
| Avg. Volume | 1.93M USD |
| Market Cap | 5.41M USD |
| Beta (5Y Monthly) | 1.716 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -62.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.5 USD |
BCTX Valuation Measures
| Enterprise Value | 6.99M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0469232 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.4217116 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.288 |
Trading Information
BriaCell Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.716 |
| 52-Week Change | 15.94% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 9.82 USD |
| 52 Week Low | 0.35 USD |
| 50-Day Moving Average | 2.89 USD |
| 200-Day Moving Average | 2.44 USD |
BCTX Share Statistics
| Avg. Volume (3 month) | 1.93M USD |
| Avg. Daily Volume (10-Days) | 4.42M USD |
| Shares Outstanding | 6.78M |
| Float | 5.78M |
| Short Ratio | 0.31 |
| % Held by Insiders | 7.32% |
| % Held by Institutions | 10.87% |
| Shares Short | 210.32K |
| Short % of Float | 3.28% |
| Short % of Shares Outstanding | 3.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2024 |
| Most Recent Quarter (mrq) | April 30, 2025 |
| Next Fiscal Year End | July 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -131.53% |
| Return on Equity (ttm) | -688.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -24266070 USD |
| Net Income Avi to Common (ttm) | -19434662 USD |
| Diluted EPS (ttm) | -7.69 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.46M USD |
| Total Cash Per Share (mrq) | 1.84 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.414 |
| Book Value Per Share (mrq) | 1.893 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24073804 USD |
| Levered Free Cash Flow (ttm) | -14592053 USD |
Profile of BriaCell Therapeutics
| Country | United States |
| State | BC |
| City | West Vancouver |
| Address | Bellevue Centre |
| ZIP | V7T 2X1 |
| Phone | 604-921-1810 |
| Website | https://briacell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Q&A For BriaCell Therapeutics Stock
What is a current BCTX stock price?
BriaCell Therapeutics BCTX stock price today per share is 11 USD.
How to purchase BriaCell Therapeutics stock?
You can buy BCTX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics?
The stock symbol or ticker of BriaCell Therapeutics is BCTX.
Which industry does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics industry is Biotechnology.
How many shares does BriaCell Therapeutics have in circulation?
The max supply of BriaCell Therapeutics shares is 1.88M.
What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics PE Ratio is now.
What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics EPS is -62.19 USD over the trailing 12 months.
Which sector does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics sector is Healthcare.
BriaCell Therapeutics BCTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
- {{ link.label }} {{link}}